In another study, PCV addition to radiotherapy in anaplastic oligodendroglioma patients is not restricted to tumors with 1p/19q co-deletion but also to ATRX and IDH mutations [89]. This evidence concerns the gene IDH1 and anaplastic oligodendroglioma.